|
R3HDM2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.6587999952562E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.79720000001738E-06 |
| Normal-vs-Stage2 |
1.470180E-02 |
| Normal-vs-Stage3 |
7.89020000002694E-07 |
| Normal-vs-Stage4 |
3.76459999995582E-06 |
| Stage1-vs-Stage2 |
3.811800E-01 |
| Stage1-vs-Stage3 |
2.757200E-01 |
| Stage1-vs-Stage4 |
2.572800E-01 |
| Stage2-vs-Stage3 |
1.618850E-01 |
| Stage2-vs-Stage4 |
1.536190E-01 |
| Stage3-vs-Stage4 |
8.904400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.50750000038613E-07 |
| Normal-vs-AfricanAmerican |
9.57929999999552E-05 |
| Normal-vs-Asian |
8.016100E-02 |
| Caucasian-vs-AfricanAmerican |
8.208200E-01 |
| Caucasian-vs-Asian |
2.529800E-01 |
| AfricanAmerican-vs-Asian |
2.742600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.30380000004948E-06 |
| Normal-vs-Female |
1.7330999968479E-09 |
| Male-vs-Female |
5.542400E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.135720E-02 |
| Normal-vs-Age(41-60Yrs) |
9.11669995051767E-09 |
| Normal-vs-Age(61-80Yrs) |
1.96853999999691E-05 |
| Normal-vs-Age(81-100Yrs) |
1.552040E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.555200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.968800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.156600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.842100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.967600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.709600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.46640000004061E-06 |
| Normal-vs-Grade 2 |
2.57700000005912E-07 |
| Normal-vs-Grade 3 |
1.59212999999436E-05 |
| Normal-vs-Grade 4 |
2.94639999998125E-06 |
| Grade 1-vs-Grade 2 |
1.153520E-02 |
| Grade 1-vs-Grade 3 |
3.621300E-03 |
| Grade 1-vs-Grade 4 |
7.551500E-02 |
| Grade 2-vs-Grade 3 |
3.924600E-01 |
| Grade 2-vs-Grade 4 |
4.271200E-01 |
| Grade 3-vs-Grade 4 |
1.537360E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.4169999969852E-08 |
| Normal-vs-ccB subtype |
1.82360000000603E-06 |
| ccA subtype-vs-ccB subtype |
6.567600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.86399999774412E-08 |
| Normal-vs-N1 |
5.236800E-03 |
| N0-vs-N1 |
9.376400E-01 |
|
|
